Prognostic value of donor chimerism at +90 days after allogeneic hematopoietic stem cell transplantation in young patients with intermediate-risk acute myeloid leukemia

Yang FEI; Xiaoxia HU; Qi CHEN; Aijie HUANG; Hui CHENG; Xiong NI; Huiying QIU; Lei GAO; Gusheng TANG; Jie CHEN; Weiping ZHANG; Jianmin YANG; Jianmin WANG.
Chinese Journal of Hematology ; (12): 990-995, 2019.
Artículo en Zh | WPRIM | ID: wpr-800484

Documentos relacionados

  1. [Prognostic value of donor chimerism at +90 days after allogeneic hematopoietic stem cell transplantation in young patients with intermediate-risk acute myeloid leukemia].
  2. Prognostic value of donor chimerism at +90 days after allogeneic hematopoietic stem cell transplantation in young patients with intermediate-risk acute myeloid leukemia
  3. Cladribine- and decitabine-containing conditioning regimen has a low post-transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.